BMS & Others Partner with WPI

6/9/11Follow @xconomy

Today Worcester Polytechnic Institute (WPI) announced that Abbott Laboratories, New York-based Bristol-Myers Squibb, and Shire Human Genetic Therapies of Cambridge, MA, will be inaugural partners of the school’s Biomanufacturing Education and Training Center, which is under construction. The facility, which is partially funded by a Massachusetts Life Sciences Center grant, is expected to be ready in late 2012 and will be a biomanufacturing pilot plant that provides training and education for those developing drugs and researching compounds using engineered living cells.

By posting a comment, you agree to our terms and conditions.